OMER Q2 2020 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M-49.4% YoY

Gross Profit

$13M98.9% margin

Operating Income

-$28M-204.6% margin

Net Income

-$33M-246.1% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

-42.5%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$71M

Total Liabilities

$232M

Stockholders' Equity

-$161M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$27M	-49.4%
Gross Profit	$13M	$27M	-49.9%
Operating Income	-$28M	-$9M	-196.4%
Net Income	-$33M	-$14M	-130.4%